THE PREVALENCE OF AUTOIMMUNITY AND RELATIONSHIP TO CARDIAC STATUS IN PEDIATRIC MYOCARDITIS AND RECENT ONSET DILATED CARDIOMYOPATHY  by Simpson, Kathleen et al.
E1265
JACC March 12, 2013
Volume 61, Issue 10
Pericardial/Myocardial Disease/Pulmonary Hypertension
The prevalence of auToimmuniTy and relaTionship To cardiac sTaTus in pediaTric 
myocardiTis and recenT onseT dilaTed cardiomyopaThy
Poster Contributions
Poster Sessions, Expo North
Sunday, March 10, 2013, 9:45 a.m.-10:30 a.m.
Session Title: Myocarditis: Mechanistic Insights
Abstract Category: 23. Pericardial/Myocardial Disease
Presentation Number: 1207-150
Authors: Kathleen Simpson, Caroline K. Lee, Madeleine Cunningham, Catherine Simon, Jeffrey Delaney, Kent Ward, Alan Tong, Saar Danon, Charles 
Canter, Washington University Saint Louis, Saint Louis, MO, USA
Background: Recent adult and animal studies have linked autoimmunity to host proteins to the pathophysiology of myocarditis/recent onset 
dilated cardiomyopathy (MC/DCM) in rodents and adults. The prevalence of autoimmunity in pediatric myocarditis and its relationship to outcome 
and cardiac dysfunction is unknown.
methods: Evidence of autoimmunity was evaluated by measuring serum titers of autoantibodies to human cardiac myosin (HCM), beta-1 and 2 
adrenergic receptors (BAR1 and BAR2), and muscarinic-2 receptor (M2) as well as antibody-mediated protein kinase A activation (PKA) in children 
with acute MC/ DCM (N=16) at presentation, previously diagnosed (<6 years, but > 6 months since diagnosis) MC/ DCM (N=12), and healthy 
age-matched controls (N=16). LV systolic dysfunction was defined as an LV shortening fraction (LVSF) echocardiographic z-score < -2 with recovery 
defined as improvement of LVSF z-score to > -2.
results: Presenting clinical and echocardiographic findings were similar with a mean LVSF z-score of -8.6 (-17.5 to -3.4) in the presentation 
group and -10.9 (-19.4 to 0.85) in the previously diagnosed group (p= 0.336). Antibodies against HCM were significantly higher in both newly (400 
vs. 200, p=0.006) and previously (400 vs. 200, p=0.004) diagnosed groups compared to controls. PKA activation was also signficiantly higher in 
newly (21 vs. -2.5, p=0.013) and previously (31.5 vs. -2.5, p=0.002) diagnosed groups compared to controls. HCM and PKA activation did not differ 
between the newly and previously diagnosed groups. Previously diagnosed patients had 75% recovery at a median follow-up of 24 months, but there 
was no difference in any titer levels or PKA activation based on recovery status.
conclusions: Autoimmune activation is present in pediatric MC/DCM at diagnosis and persists with follow-up. No apparent relationship 
between autoantibody production or PKA activation with recovery of normal systolic function could be discerned in this pilot study, but will require 
confirmation with a larger study population.
